145 related articles for article (PubMed ID: 36804163)
1. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
2. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
3. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
5. Assessment of brush biopsy findings and salivary LDH levels in oral mucosal lesions of tobacco users.
Davidson SP; Kumar S; Somasundaram E; Jaishankar S
Indian J Dent Res; 2023; 34(2):191-195. PubMed ID: 37787211
[TBL] [Abstract][Full Text] [Related]
6. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case-Control Study.
López-Jornet P; Olmo-Monedero A; Peres-Rubio C; Pons-Fuster E; Tvarijonaviciute A
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958429
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Serum and Salivary Lactate Dehydrogenase Levels in Patients with Oral Potentially Malignant Conditions/Lesions: A Clinical and Biochemical Study.
Rao K; Babu SG; Shetty SR; Castelino RL
Indian J Community Med; 2024; 49(2):316-321. PubMed ID: 38665466
[TBL] [Abstract][Full Text] [Related]
9. Salivary and serum levels of lactate dehydrogenase in oral submucous fibrosis: A meta-analysis.
Chen X; Chen T; Xie H; Guo J
Medicine (Baltimore); 2024 Apr; 103(15):e37788. PubMed ID: 38608075
[TBL] [Abstract][Full Text] [Related]
10. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients-a systematic review with meta-analysis.
Nazar NSBM; Ramanathan A; Ghani WMN; Rokhani FB; Jacob PS; Sabri NEB; Hassan MS; Kadir K; Dharmarajan L
Clin Oral Investig; 2024 Jan; 28(1):98. PubMed ID: 38225483
[TBL] [Abstract][Full Text] [Related]
11. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.
Yasothkumar D; Ramani P; Jayaraman S; Ramalingam K; Tilakaratne WM
Head Neck Pathol; 2024 Mar; 18(1):28. PubMed ID: 38536520
[TBL] [Abstract][Full Text] [Related]
12. Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.
Li H; Liu Y; Zhou S; Zhou Q; Yang X
BMC Oral Health; 2023 Sep; 23(1):659. PubMed ID: 37697274
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
14. Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
Fathima R; Ramamoorthi R; Gopalakrishnan S; Jayaseelan VP; Muniapillai S
J Oral Maxillofac Pathol; 2024; 28(1):84-89. PubMed ID: 38800445
[TBL] [Abstract][Full Text] [Related]
15. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
[TBL] [Abstract][Full Text] [Related]
16. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
[TBL] [Abstract][Full Text] [Related]
17. Oral somatosensory alterations and salivary dysfunction in head and neck cancer patients.
Riantiningtyas RR; Valenti A; Dougkas A; Bredie WLP; Kwiecien C; Bruyas A; Giboreau A; Carrouel F
Support Care Cancer; 2023 Oct; 31(12):627. PubMed ID: 37828382
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of salivary tumor necrosis factor
Abdul Aziz Shaikh S; Denny E C; Kumarchandra R; Natarajan S; Sunny J; Shenoy N; K P N
Front Oral Health; 2024; 5():1375162. PubMed ID: 38595736
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Salivary Biomarkers in Detecting Early Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shaw AK; Garcha V; Shetty V; Vinay V; Bhor K; Ambildhok K; Karande P
Asian Pac J Cancer Prev; 2022 May; 23(5):1483-1495. PubMed ID: 35633529
[TBL] [Abstract][Full Text] [Related]
20. Salivary biomarkers: Effective diagnostic tool for oral leukoplakia and oral squamous cell carcinoma.
Liew YX; Kadir K; Phan CW; Leong KH; Kallarakkal TG; Tilakaratne WM
Oral Dis; 2023 Dec; ():. PubMed ID: 38098264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
